Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1&#945; inhibition.

Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition.

Wang, Jian; Lv, Xin; A-Ni-Wan, A-Shan-Jiang; Tian, Sha-Sha; Wang, Jun-Mei; Liu, Hong-Yan; Fan, Xiao-Guang; Zhou, Sai-Jun; Yu, Pei.

Afiliação

Wang J; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Lv X; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China.
A-Ni-Wan AS; Department of Nephrology, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Tian SS; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Wang JM; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China.
Liu HY; Department of Nephrology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Fan XG; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Zhou SJ; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China.
Yu P; NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.